Drug Database
Back to search

Czechia· CZ-0251739

TELMISARTAN/AMLODIPIN TEVA

A telmisartan and amlodipine product, registered in Czechia by Teva B.V., Haarlem. The same ATC class is registered in 11 of our 19 countries.

ATC C09DB04

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedTELMISARTAN/AMLODIPIN TEVAATCC09DB04REGISTER NO.CZ-0251739PACKS LISTED0CHECKEDJune 22, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about TELMISARTAN/AMLODIPINAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Telmisartan and amlodipine is registered in 11 of 19 countries.

Countries holding a registration under ATC C09DB04 (telmisartan and amlodipine), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose
Search telmisartan and amlodipine products by name

Telmisartan and amlodipine · ATC C09DB04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Manufacturer
Teva B.V., Haarlem
Country
Czechia (CZ)
ATC code
C09DB04
ATC class
Telmisartan and amlodipine
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
June 22, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

46 interactions on record for telmisartan and amlodipine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check telmisartan and amlodipine against other medicinesHow interaction checks work

Telmisartan and amlodipine · interactions on record

46 records

46 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under C09DB04

Telmisartan and amlodipine, as other registers publish it.

All telmisartan and amlodipine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cb3efefd-e485-4a0d-8a93-538b2a833373
GET /v1/drugs/cb3efefd-e485-4a0d-8a93-538b2a833373?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL NOB",
  "source": "sukl",
  "strength": "80MG/5MG",
  "pack_size": "98",
  "substance": "13774,12990",
  "cz_kod_sukl": "0251739",
  "product_type": "CH",
  "registration_state": "R",
  "registration_number": "58/439/20-C"
}
API referenceMCP serverPlans

See everything about telmisartan and amlodipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console